Chris Molineaux

#1501 - While analysts still see strong potential in the biotech sector, they also acknowledge that life sciences industry is in an era of significant transition, with ongoing health care reform, an aging population and workforce, and new, more targeted treatment options. What does this mean for biotechnology companies? Will the industry continue to expand? Will M&A pressure blur the lines between biotechnology and pharmaceuticals even further? What skills do leaders need to shape the biotechnology companies of the future? Mindy Hall discusses the changing landscape of the biotechnology industry with President and CEO of Pennsylvania Bio, Chris Molineaux.

Listen to the podcast now using the play button below. Or subscribe in iTunes or on Stitcher radio on demand to listen to episodes on your computer, on your phone, or on your commute.

The post The Future of Biotech appeared first on Peak Development.